Q/C TECHNOLOGIES, INC. (QCLS)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 12, 2026 | CORRESP | Neutral/Informational | Moderate | Q/C Technologies, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, which was filed on February 11, 2… | Read Filing EDGAR |
| Jan. 28, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Q/C Technologies, Inc. that they do not intend to review the company's draft registration statement submitted on January 23, 2026. The SEC has requeste… | Read Filing EDGAR |
| Nov. 25, 2025 | CORRESP | Neutral/Informational | Moderate | Q/C Technologies, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-3, originally filed on October 3, 2025. The compa… | Read Filing EDGAR |
| Sep. 18, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of TNF Pharmaceuticals, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management of their responsi… | Read Filing EDGAR |
| Aug. 19, 2025 | CORRESP | Concern from SEC | Moderate | The correspondence from TNF Pharmaceuticals, Inc. addresses comments received from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised se… | Read Filing EDGAR |
| Aug. 5, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed TNF Pharmaceuticals, Inc.'s Form 10-K for the fiscal year ended December 31, 2024, and has issued several comments regarding the accuracy and clarity of the c… | Read Filing EDGAR |